sorafenib has been researched along with eicosapentaenoic acid in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (eicosapentaenoic acid) | Trials (eicosapentaenoic acid) | Recent Studies (post-2010) (eicosapentaenoic acid) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 7,171 | 1,304 | 3,623 |
| Protein | Taxonomy | sorafenib (IC50) | eicosapentaenoic acid (IC50) |
|---|---|---|---|
| Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | Homo sapiens (human) | 4 | |
| Prostaglandin G/H synthase 2 | Ovis aries (sheep) | 7.1 | |
| Oxoeicosanoid receptor 1 | Homo sapiens (human) | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, QX; Cheng, J; Fan, YQ; Liu, BH; Wang, JM; Zhou, H | 1 |
1 other study(ies) available for sorafenib and eicosapentaenoic acid
| Article | Year |
|---|---|
ACSL4 suppresses glioma cells proliferation via activating ferroptosis.
Topics: Adult; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coenzyme A Ligases; Down-Regulation; Eicosapentaenoic Acid; Ferroptosis; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; RNA, Small Interfering; Sorafenib | 2020 |